🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I'll be speaking at the 35th International Prostate Cancer Update conference in Vail, CO, on February 9-12. Join or register to hear me discuss oligometastatic prostate cancer in the PSMA PET era and the future of AR-directed therapy. #IPCU35

Breaking News 👉ASCO #GU25 Abstracts are out! For full-length abstracts, here is the weblink👉bit.ly/3WT81de OncoAlert UroToday.com Uromigos Oncology Brothers PCF Science

Ab#77 ASCO #GU25 by Heather H. Cheng 👉 bit.ly/4aSURTA👉mHSPC #prostatecancer w/ BRCA1/2 alt had significantly worse TTNT & TTCR than those with no HRR alt 👉Need for early identification & more effective Rx for these pts 👇Mehmet Asim Bilen,MD OncoAlert UroToday.com PCF Science

Ab#104 ASCO #GU25 by Umang Swami👉bit.ly/3CIfFAy👉In pts with mHSPC #prostatecancer in Flatiron Health 👉Glad to report an improved utilization of intensified ADT in 77% of pts since January 2023👇GU Cancer Research Program @HuntsmanCancer OncoAlert UroToday.com PCF Science

Ab#310 ASCO #GU25 by #AbdenourNabid👉bit.ly/4hsQ4L1👉22 years of f/u on testosterone (T) recovery in pts w/ #prostatecancer s/p RT+ADT👉T recovery to normal level associated w/ significant improvement in OS👇#LuisSouhami OncoAlert UroToday.com PCF Science

⭐️ Top 10 #GU25 Influencers so far at ASCO GU. ASCO Neeraj Agarwal, MD, FASCO OncoAlert Toni Choueiri, MD Cristiane D Bergerot Sumanta K. Pal, MD, FASCO Tom Powles Emre Yekedüz Petros Grivas Top 10 highest impressions totaling 50+ million impressions OncoAlert ASCO UroToday.com OncLive.com Gil Morgan, MD Nazli Dizman

Outstanding talk and discussion on emerging treatment landscape of mRCC #kidneycancer by Tian Zhang, MD, MHS 👉 emphasizes the need to personalize treatment in mRCC #kidneycancer 👉next gen trials 👇UroToday.com KidneyCAN OncoAlert Kidney Cancer #GU25 ASCO Andrea Apolo, M.D.

Congrats to Toni Choueiri, MD Robert Motzer MD for developing one of the most effective combinations cabozantinib + nivolumab for mRCC #kidneycancer 👉Checkmate 9ER phase 3 trial👉continued strong OS benefit Tom Powles Laurence Albiges @asco #GU25 OncoAlert UroToday.com KidneyCAN Kidney Cancer 👇

Just in European Urology 👉Overview of T-cell engagers (TCEs) in #prostatecancer👉promising anti-tumor activity, but challenges remain👇Congrats @chadihc98 Zeynep Irem Ozay, MD and the team GU Cancer Research Program @HuntsmanCancer Emmanuel Antonarakis Arun Azad bit.ly/3XJlg0x

Highly encourage everyone to peruse this terrific review in European Urology from the stellar team of Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute, with lead authors Chadi Hage Chehade & Zeynep Irem Ozay, MD. I always appreciate their ability to distill complex data landscapes in thoughtful figures & tables, as you

"On the Edge of Breakthrough: Voices of Cancer Research" premiered in the top 5% of podcasts! Thank you for your support! For our second episode, I sat down with someone who is indeed one of the most interesting folks I've met in my career at City of Hope (in a good way, I

Just in JAMA Network Open👉Flatiron Health Real world Rx data from >8500 pts w/ mRCC #kidneycancer 👉After 2018, only 38% & 14% of pts received 2nd & 3rd line Rx respectively👇bit.ly/41H22dp Thanks to my mentors Umang Swami Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Cc OncoAlert UroToday.com

Just in👉Two The Lancet Oncology papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCRPC #ProstateCancer pts👉Improved OS without compromising QOL👇Links: bit.ly/3DWHlSR & bit.ly/3E3SSQi UroToday.com OncoAlert Prostate Cancer Foundation 👇

Examining post-prostatectomy metastasis patterns in hormone-sensitive #ProstateCancer. Nicolas Sayegh, MD sits down with Neeraj Agarwal, MD, FASCO to discuss research investigating whether time from prostatectomy to metastasis affects survival in #mHSPC. #WatchNow on UroToday >

This week we went to DC with ASCO member Sumanta K. Pal, MD, FASCO for the #ASCOAdvocacySummit. Follow his day as he met with fellow ASCO advocates and Members of Congress. You can still take action online: brnw.ch/21wRWHX

🧩 ctDNA is a key piece of the puzzle in building an integrated precision oncology ecosystem at Weill Cornell Medicine Excited to share collaborative paper #2 this month. This time with the brilliant Alexandre Pellan Cheng & Dan Landau! rdcu.be/ehkUb Nature Methods Highlights: 🔬

We invite you to ASCO IMG Oncologists today 4-6pm at #ASCO25 McCormick Place. ROOM S103 Ziad Bakouny, MD, MSc Nazli Dizman

#ASCO2025 Powerful letter from ASCO #DailyNews Editor Neeraj Agarwal, MD, FASCO “In the fight against cancer, we are united by purpose.” Thx for all your hard work & dedication to making this the most valuable free resource for oncology professionals 🌏 by bringing key insights from

Stellar presentation ASCO #ASCO25 by trailblazer Rana McKay, MD, FASCO on ETCTN trial with radium +|- olaparib in mCRPC #prostatecancer 👉rPFS ⬆️ with the combo w/wo HRRm👇Data continues to reinforce role of PARPi in rationale combinations Toni Choueiri, MD (mentor), UroToday.com OncoAlert

Top #GUCancer Oncologists from ASCO 2025. Follow us for more #ASCO25 updates: t.ly/7TCD6 #LARVOL #GenitourinaryCancer #CancerResearch #Oncology #CancerData #ClinicalTrials #OncologyInsights #ASCO2025 | Toni Choueiri, MD | Neeraj Agarwal, MD, FASCO | Andrea Necchi | Tom Powles |